Semaglutide has rising clinical utility, both for its original purpose in managing type-II diabetes symptoms and, more recently, as a tool for weight management
It's not a medical condition.' And so the validity of obesity as a chronic medical condition continues to be questioned, despite evidence, despite the neurobiology of obesity and how we understand obesity in 2024, despite treatments that really show benefits in terms of outcomes and weight loss," he said
Factors such as tolerance, medical history, lifestyle, and close professional monitoring ultimately determine whether a therapy is appropriate and sustainable
Significant hypoglycemia risk mainly arises when semaglutide is combined with insulin or sulfonylureas, not typically as monotherapy
Additionally, over three times the number of people taking the drug achieved a 5% reduction, a generally accepted baseline for clinically meaningful weight loss
Theres a lots of them